Regulatory authorities and orthopaedic clinical trials on expanded mesenchymal stem cells

International Orthopaedics

Volumn 38, Issue 9, 2014, Pages 1803-1809

  Gómez Barrena, Enrique ^a   Solá, Cristina Avendaño ^a   Bunu, Carmen Painatescu ^b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

AMTP; Bone regeneration; Cell therapy; Clinical trials; European regulation; MSC

Indexed keywords

BONE CELL; BONE CELL THERAPY; BONE INJURY; BONE REGENERATION; CELL THERAPY; CLINICAL TRIAL (TOPIC); HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; ORTHOPEDIC SURGEON; ORTHOPEDICS; PRIORITY JOURNAL; REVIEW; SAFETY; BIOLOGICAL THERAPY; BONE DISEASES; ETHICS; EUROPE; LEGISLATION AND JURISPRUDENCE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PROCEDURES;

BONE DISEASES; BONE REGENERATION; CELL- AND TISSUE-BASED THERAPY; CLINICAL TRIALS AS TOPIC; EUROPE; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; ORTHOPEDICS;

EID: 84922833812     PISSN: 03412695     EISSN: 14325195     Source Type: Journal    
DOI: 10.1007/s00264-014-2332-z     Document Type: Review

References (17)

1. Gomez-Barrena E, Rosset P, Muller I, Giordano R, Bunu C, Layrolle P, Konttinen YT, Luyten FP (2011) Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology. J Cell Mol Med 15(6):1266-1286. doi:10.1111/j.1582-4934.2011.01265.x
2. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, Begum N, Shah R, Karyana M, Kosen S, Farje MR, Moncada G, Dutta A, Sazawal S, Dyer A, Seiler J, Aboyans V, Baker L, Baxter A, Benjamin EJ, Bhalla K, Bin Abdulhak A, Blyth F, Bourne R, Braithwaite T, Brooks P, Brugha TS, Bryan-Hancock C, Buchbinder R, Burney P, Calabria B, Chen H, Chugh SS, Cooley R, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, Davis A, Degenhardt L, Diaz-Torne C, Dorsey ER, Driscoll T, Edmond K, Elbaz A, Ezzati M, Feigin V, Ferri CP, Flaxman AD, Flood L, Fransen M, Fuse K, Gabbe BJ, Gillum RF, Haagsma J, Harrison JE, Havmoeller R, Hay RJ, Hel-Baqui A, Hoek HW, Hoffman H, Hogeland E, Hoy D, Jarvis D, Karthikeyan G, Knowlton LM, Lathlean T, Leasher JL, Lim SS, Lipshultz SE, Lopez AD, Lozano R, Lyons R, Malekzadeh R, Marcenes W, March L, Margolis DJ, McGill N, McGrath J, Mensah GA, Meyer AC, Michaud C, Moran A, Mori R, Murdoch ME, Naldi L, Newton CR, Norman R, Omer SB, Osborne R, Pearce N, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Pourmalek F, Prince M, Rehm JT, Remuzzi G, Richardson K, Room R, Saha S, Sampson U, Sanchez-Riera L, Segui-Gomez M, Shahraz S, Shibuya K, Singh D, Sliwa K, Smith E, Soerjomataram I, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Taylor HR, Tleyjeh IM, van der Werf MJ, Watson WL, Weatherall DJ, Weintraub R, Weisskopf MG, Whiteford H, Wilkinson JD, Woolf AD, Zheng ZJ, Murray CJ, Jonas JB (2012) Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 380(9859):2129-2143. doi:10.1016/s0140-6736(12)61680-8
3. WHO (2003) The burden of musculoskeletal conditions at the start of the new millennium. WHO technical report series 919. World Health Organization, Geneva
4. Mock C, Cherian MN (2008) The global burden of musculoskeletal injuries: challenges and solutions. Clin Orthop Relat Res 466(10):2306-2316. doi:10.1007/s11999-008-0416-z
5. Heinegard D, Johnell O, Lidgren L, Nilsson O, Rydevik B, Wollheim F, Akesson K (1998) The bone and joint decade 2000-2010. Acta Orthop Scand 69(3):219-220
6. The Bone and Joint Decade (2014) http://bjdonline.org. Accessed 24 Feb 2014
7. Mills LA, Simpson AH (2013) The relative incidence of fracture non-union in the Scottish population (5.17 million): a 5-year epidemiological study. BMJ Open 3(2):e002276. doi:10.1136/bmjopen-2012-002276
8. Kanis JA, Johnell O, Oden A, Sembo I, Redlund-Johnell I, Dawson A, De Laet C, Jonsson B (2000) Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int 11(8):669-674
9. Alves SM, Economou T, Oliveira C, Ribeiro AI, Neves N, Gomez-Barrena E, Pina MF (2013) Osteoporotic hip fractures: bisphosphonates sales and observed turning point in trend. A population-based retrospective study. Bone 53(2):430-436. doi:10.1016/j.bone.2012.12.014
10. Crisan M, Chen CW, Corselli M, Andriolo G, Lazzari L, Peault B (2009) Perivascular multipotent progenitor cells in human organs. Ann NY Acad Sci 1176:118-123. doi:10.1111/j.1749-6632.2009.04967.x
11. EMA European Medicines Agency. Risk-management plans. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document-listing/ document-listing-000360.jsp. Accessed 12 Mar 2014
12. Maciulaitis R, D'Apote L, Buchanan A, Pioppo L, Schneider CK (2012) Clinical development of advanced therapymedicinal products in Europe: evidence that regulators must be proactive. Mol Ther: J Am Soc Gene Ther 20(3):479-482. doi:10.1038/mt.2012.13
13. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315-317. doi:10.1080/ 14653240600855905
14. Giannoni P, Muraglia A, Giordano C, Narcisi R, Cancedda R, Quarto R, Chiesa R (2009) Osteogenic differentiation of human mesenchymal stromal cells on surface-modified titanium alloys for orthopedic and dental implants. Int J Artif Organs 32(11):811-820
15. Xin Y, Wang YM, Zhang H, Li J, Wang W, Wei YJ, Hu SS (2010) Aging adversely impacts biological properties of human bone marrow-derived mesenchymal stem cells: implications for tissue engineering heart valve construction. Artif Organs 34(3):215-222. doi:10.1111/j.1525-1594.2009.00824.x
16. Druml C, Wolzt M, Pleiner J, Singer EA (2009) Research ethics committees in Europe: trials and tribulations. Intensive Care Med 35(9):1636-1640. doi:10.1007/s00134-009-1544-y
17. HMAs Clinical Trials Facilitation Group (2013) Guidance document for sponsors for a voluntary harmonisation procedure (VHP) for the assessment of multinational clinical trial applications. http://www.hma.eu/fileadmin/dateien/ Human-Medicines/01-About-HMA/Working-Groups/CTFG/2013-04-CTFG-VHP-v3.pdf. Accessed 12 Mar 2014